Sentinel lymph node biopsy for breast cancer: from investigational procedure to standard practice

References

• Donegan WL. Tumor-related prognostic factors for breast cancer. CA Cancer 1 Gun. 47,28-51 (1997).
   Google Scholar
• Fisher B, Jeong JH, Anderson S et al. Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy followed by irradiation. N. Eng. J. Med 347(8), 567–575 (2002).
   Google Scholar
• ••25-year follow-up results of the landmark National Surgical Adjuvant Breast and Bowel Project (NSABP) B-04 study, demonstrating no survival advantage to axillary node dissection.
   Google Scholar
• Lin PP, Allison DC, Wainstock J et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. Clin. Onco1.11, 1536–1544 (1993).
   Google Scholar
• Morton D, Wen DR, Wong J et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 11,105–116 (1992).
   Google Scholar
• •Initial work in melanoma, laying the groundwork for sentinel lymph node biopsy (SLNB) in breast cancer.
   Google Scholar
• Giuliano AE, Kirgan DM, Guenther JM et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 220,391–401 (1994).
   PubMed Web of Science ®Google Scholar
• •Initial study introducing SLNB for breast cancer.
   Google Scholar
• Krag DN, Weaver OJ, Alex JC et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol 2, 335–340 (1993).
   PubMed Web of Science ®Google Scholar
• Albertini JJ, Lyman GH, Cox C et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JA /V/A 276,1818–1822 (1996).
   PubMed Web of Science ®Google Scholar
• McMasters KM, Tuttle TM, Carlson DJ et al. Sentinel lymph node biopsy in breast cancer, a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. Gun. Onto]. 18,2560–2566 (2000).
   PubMed Web of Science ®Google Scholar
• ••large prospective multicenter validationstudy demonstrating the feasibility of SLNB in breast cancer.
   Google Scholar
• Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma, an alternative to routine axillary dissection. J. Surg. Oncol 62,75–77 (1996).
   PubMed Web of Science ®Google Scholar
• ••Validation of SLNB in breast cancer.
   Google Scholar
• Krag D, Weaver D, Ashikaga T et al The sentinel node in breast cancer, a multicenter validation study. N Engl. J. Merl 339,941–946 (1998).
   PubMed Web of Science ®Google Scholar
• ••Validation of SLNB in breast cancer.
   Google Scholar
• Veronesi U, Paganelli G, Galimberti V et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349, 1864–1867 (1997).
   PubMed Web of Science ®Google Scholar
• ••Validation of SLNB in breast cancer.
   Google Scholar
• Haddad FF, Costello D, Reintgen DS. Radioguided surgery for melanoma. Surg. Oncol Gun. North Am. 8,413–426 (1999).
   PubMedGoogle Scholar
• McMasters KM, Wong SL, Tuttle TM et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann. Surg. 231,724–731 (2000).
   PubMed Web of Science ®Google Scholar
• DuPont EL, Kamath VJ, Ramnath EM et al. The role of lymphoscintigraphy in the management of the patient with breast cancer. Ann. Surg. Oncol 8,354–360 (2001).
   PubMed Web of Science ®Google Scholar
• Csemi G, Szekeres JR Internal mammary lymph nodes and sentinel node biopsy in breast cancer. Surg. Oncol 10,25–33 (2001).
   PubMed Web of Science ®Google Scholar
• Noguchi M. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients. Surg. Oncol 76,144–156 (2001).
   Google Scholar
• Rubio IT, Klimberg VS. Techniques of sentinel lymph node biopsy. Semin. Surg. Oncol 20,214–223 (2001).
   PubMedGoogle Scholar
• Guiliano AE. Sentinel lymphadenectomy in primary breast carcinoma, an alternative to routine axillary dissection. J. Surg. Oncol 62,75–77 (1996).
   PubMed Web of Science ®Google Scholar
• Krag DN, Meijer SJ, Weaver DL et al. Minimal access surgery for staging of malignant melanoma. Atrh. Surg. 130, 654–660 (1995).
   Web of Science ®Google Scholar
• Giuliano AE, Barth AM, Spivak B et al. Incidence and predictors of axillary metastasis in Ti carcinoma of the breast. J. Am. Coll Surg. 183,45–49 (1996).
   Web of Science ®Google Scholar
• Giuliano AE, Jones RC, Brennan M et al. Sentinel lymphadenectomy in breast cancer. 1 Gun. Oncol 15,2345–2350 (1997).
   Google Scholar
• Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J. Sc]. Am. 3,336–340 (1997).
   Google Scholar
• Feldman SM, Krag DN, McNally RK et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J. Am. Coll Surg. 188,248–254 (1999).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Paganelli G, Viale G et al. Sentinel lymph node biopsy and axillary dissection in breast cancer, results in a large series. J. Natl Cancer Inst. 91,368–373 (1999).
   PubMedGoogle Scholar
• Moffat FL Jr, Gulec SA, Sittler SY et al. Unfiltered sulfur colloid and sentinel node biopsy for breast cancer, technical and kinetic considerations. Ann. Surg. Oncol 6, 746–755 (1999).
   PubMed Web of Science ®Google Scholar
• Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 349, 1668–1669 (1997).
   Google Scholar
• Viale G, Bosari S, Mazzarol G et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85,2433–2438 (1999).
   PubMed Web of Science ®Google Scholar
• Schlag PM, Bembenek A. Specification of potential indications and contraindications of sentinel lymph node biopsy in breast cancer. Recent Results Cancer Res. 157, 228–236 (2000).
   PubMedGoogle Scholar
• Krag DN, Harlow S, Weaver D, Ashikaga T Radiolabeled sentinel node biopsy, collaborative trial with the National Cancer Institute. Workif Surg. 25, 823–828 (2001).
   PubMed Web of Science ®Google Scholar
• Quan ML, McCready D, Temple WJ, McKinnon JG. Biology of lymphatic metastases in breast cancer, lessons learned from sentinel node biopsy. Ann. Surg. Oncol 9,467–471 (2002).
   PubMed Web of Science ®Google Scholar
• OHea BJ, Hill AD, El-Shirbiny AM et al. Sentinel lymph node biopsy in breast cancer, initial experience at Memorial Sloan—Kettering Cancer Center. J. Am. Coll Surg. 186,423–427 (1998).
   PubMed Web of Science ®Google Scholar
• Molland JG, Dias MM, Gillett DJ. Sentinel node biopsy in breast cancer, results of 103 cases. Aust. NZI Surg. 70, 98–102 (2000).
   Google Scholar
• Nwariaku RE, Euhus DM, Beitsch RD et al. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer. Am. J. Surg. 176,529–531 (1998).
   PubMed Web of Science ®Google Scholar
• Bass SS, Cox CE, Ku NN et al. The role of sentinel lymph node biopsy in breast cancer. J. Am. Coll Surg. 189,183–194 (1999).
   PubMed Web of Science ®Google Scholar
• Haigh PI, Hansen NM, Qi K et al. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann. Surg. Oncol 7,21–27 (2000).
   PubMed Web of Science ®Google Scholar
• Nano MT, Kollias J, Farshid G, Gill PG, Bochner M. Clinical impact of false-negative sentinel node biopsy in primary breast cancer. BE I Surg. 89,1430–1434 (2002).
   Google Scholar
• Shivers S, Cox C, Leight G et al. Final results of the Department of Defense multicenter breast lymphatic mapping trial. Ann. Surg. Oncol 9,248–255 (2002).
   PubMed Web of Science ®Google Scholar
• Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am. J. Surg. 182,312–315 (2001).
   Google Scholar
• Bergkvist L, Frisell J, Liljegren G et al. Multicenter study of detection and false-negative rates in sentinel node biopsy for breast cancer. BE I Surg. 88,1644–1648 (2001).
   PubMed Web of Science ®Google Scholar
• Doting MH, Jansen L, Niewing OE et al. Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer88, 2546–2552 (2000).
   PubMed Web of Science ®Google Scholar
• McMasters KM, Wong SL, Chao E et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy, a model for implementation of new surgical technique. Ann. Surg. 234 (3), 292–300 (2001).
   PubMed Web of Science ®Google Scholar
• Cabanas RM. An approach for the treatment of penile cancer. Cancer 39(2), 456–466 (1977).
   PubMed Web of Science ®Google Scholar
• •Initial study demonstrating SLNB as a technique that has clinical applicability in breast cancer.
   Google Scholar
• Klimberg SV, Rubio IT, Henry R et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann. Surg. 229,860–871 (1999).
   PubMed Web of Science ®Google Scholar
• Beitsch PD, Clifford E, Whitworth P, Abarca A. Improved lymphatic mapping technique for breast cancer. Breast 1 7, 219–223 (2001).
   Google Scholar
• Tuttle TM, Colbert M, Christensen R et al. Subareolar injection of 99m-Tc facilitates sentinel lymph node identification. Ann. Surg. Oncol 9,77–81 (2002).
   Google Scholar
• Smith LF, Cross MJ, Klimberg VS. Subareolar injection is a better technique for sentinel lymph node biopsy. Am J. Surg. 180,434–438 (2000).
   Google Scholar
• Bauer TW, Spitz FR, Callans LS et al Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer. Ann. Surg. aryl 9,169–176 (2002).
   Google Scholar
• Donahue EJ. Sentinel node imaging and biopsy in breast cancer patients. Am. J. Surg. 182,426–428 (2001).
   PubMed Web of Science ®Google Scholar
• Zavagno G, Meggiolaro F, Rossi CR et al. Subareolar injection for sentinel lymph node location in breast cancer. Eur. j Surg. Oncol 28,701–704 (2002).
   PubMedGoogle Scholar
• D'Eredita G, Ferrarese F, Cecere V et al. Subareolar injection may be more accurate than other techniques for sentinel lymph node biopsy in breast cancer. Ann. Surg. Oncol 10,942–947 (2003).
   Google Scholar
• Kern IKA. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. I Am. Coll. Surg: 189,539-545 (1999).
   Google Scholar
• Schrenk P, Wayand W Sentinel-node biopsy in axillary lymph node staging for patients with multicentric breast cancer. Lancet357, 122 (2001).
   PubMed Web of Science ®Google Scholar
• Kern IKA. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. jAm. Coll. Surg. 195,467-475 (2002).
   Google Scholar
• Chagpar A, Martin RC III, Chao C et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch. Surg. 139(6), 614–618 (2004).
   PubMedGoogle Scholar
• Wong SL, Chao C, Edwards MJ et al. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am. Surg. 182,330–334 (2001).
   Google Scholar
• Pendas S, Dauway E, Cox CE et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am. Surg. 65, 500–506 (1999).
   Google Scholar
• Schreiber RII, Pendas S, Ku NN. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann. Surg. Oncol 65,95–101 (1999).
   Google Scholar
• McIntosh SA, Going JJ, Soukop M et al. Therapeutic implications of the sentinel lymph node in breast cancer. Lancet 54, 570 (1999).
   Google Scholar
• Weaver DL, Krag DN, Ashikaga T et al. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma, a multicenter study. Cancer 88, 1099–1107 (2000).
   PubMed Web of Science ®Google Scholar
• Pargaonkar AS, Beissner RS, Snyder S, Speights VO. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch. Pathol Lab. Med. 127,701–705 (2003).
   PubMed Web of Science ®Google Scholar
• Stitzenberg KB, Calvo BF, Iacocca MV et al. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am. J. Clin. Pathol 117,729–737 (2002).
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Virmani A, Dudak MW et al. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. Ann. Surg. Oncol 10,117–125 (2003).
   PubMed Web of Science ®Google Scholar
• Manzotti M, Dell'Orto P, Maisonneuve P et al. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. int. J. Cancer 95,307–312 (2001).
   Google Scholar
• Bettelheim R, Price KN, Gelber RD et al. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335,1565–1568 (1990).
   PubMed Web of Science ®Google Scholar
• Nasser IA, Lee AKC, Bosari S et al. Occult axillary lymph node metastases in 'node negative' breast cancer. Hum. Pathol 24,950–957 (1993).
   PubMed Web of Science ®Google Scholar
• McGuckin MA, Cummings MC, Walsh MD et al Occult axillary node metastases in breast cancer, their detection and prognostic significance. BE J. Cancer 73,88–95 (1996).
   Web of Science ®Google Scholar
• Wilkinson EJ, Hause LL, Hoffman RG et al. Occult axillary lymph node metastases in invasive breast carcinoma, characteristics of the primary tumor and significance of the metastases. Pathol Annu. 17,67–91 (1982).
   PubMedGoogle Scholar
• Friedman S, Bertin F, Mouriesse H et al. Importance of tumor cells in axillary node sinus margins (clandestine metastasis') discovered by serial sectioning in operable breast carcinoma. Acta aryl 27,483–487 (1988).
   Google Scholar
• Cote RJ, Peterson HF, Chaiwun B et al Role of immunohistochemical detection of lymph node metastases in management of breast cancer. Lancet 354,896–900 (1999).
   PubMed Web of Science ®Google Scholar
• Singletary SE, Allred C, Ashley P et al. Revision of the American Joint Committee on Cancer Staging System for breast cancer. j Clin. Oncol 20, 3628–3636 (2002). American Joint Committee on Cancer Staging System that takes into account many of the issues of SLNB in breast cancer.
   Google Scholar
• Zurrida S, Mazzarol G, Galimberi V et al. The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann. Surg. Oncol 8,817–820 (2001).
   PubMed Web of Science ®Google Scholar
• Chao C, Wong SL, Ackermann D et al. Utility of intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. Am. J. Surg. 182,609–615 (2002).
   Web of Science ®Google Scholar
• Kane JM, Edge SB, Winston JS et al. Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann. Surg. Oncol 8, 361–367 (2001).
   PubMed Web of Science ®Google Scholar
• Henry-Tillman RS, Korourian S, Rubio IT et al. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann. Surg. Oncol 9,333–339 (2002).
   Google Scholar
• Shiver SA, Creager AJ, Geisinger K et al. Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. A117. I Surg. 184,424-427 (2002).
   Google Scholar
• Chao C, Abell T, Martin RC II, McMasters KM. Intraoperative frozen section of sentinel nodes: a formal decision analysis. Am Surg. 70,215–220 (2004).
   PubMed Web of Science ®Google Scholar
• McMasters KM. Editorial. The eternally enigmatic axilla: further controversy about axillary lymph nodes in cancer. Ann. Surg. Oncol 10(10), 1128–1130 (2003).
   Google Scholar
• McMasters KM. Sentinel node biopsy in breast cancer. N Engl. Med. 349(20), 1968–1971 (2003).
   Google Scholar
• Goyal A, Newcombe RG, Mansel RE. Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur. j Surg. Oncol 30,475–479 (2004).
   Google Scholar
• Layeeque R, Henry-Tillman R, Korourian S et al. Subareolar sentinel node biopsy for multiple breast cancers. Am J. Surg. 186,730–736 (2003).
   PubMed Web of Science ®Google Scholar
• Tousimis E, Van Zee KJ, Fey JV et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. j Am. Coll. Swg. 197(4), 529–535 (2003).
   Google Scholar
• Bedrosian I, Reynolds C, Mick R et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer88(1), 2540–2545 (2000).
   PubMedGoogle Scholar
• Wong SL, Chao C, Edwards MJ et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am. Surg. 67(6), 522–528 (2001).
   Google Scholar
• Chung MET, Ye W, Giuliano AE. Role for sentinel lymph node dissection in the management of large 0 cm) invasive breast cancer. Ann. Surg: Oncol 8(9), 688–692 (2001).
   Google Scholar
• Nason KS, Anderson BO, Byrd DR et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer89, 2187–2194 (2000).
   PubMed Web of Science ®Google Scholar
• Fernandez A, Cortes M, Benito E et al. Gamma probe sentinel node localization and biopsy in breast cancer patients with large excisional biopsy. jAm. Coll Surg. 188,248–254 (2001).
   Web of Science ®Google Scholar
• Stearns V, Ewing CA, Slack R et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann. Surg. Oncol 9,235–242 (2002).
   PubMed Web of Science ®Google Scholar
• Tafra L, Verbanac KM, Lannin DR. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am. Surg. 182,312–315 (2001).
   Google Scholar
• Breslin TM, Cohen L, Sahin A et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. Clin. Oncol 18,3480–3486 (2000).
   Web of Science ®Google Scholar
• Piato JR, Barros AC, Pincerato KM et al. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy, a pilot study. Eur j Surg: Oncol 29, 118–120 (2003).
   PubMedGoogle Scholar
• Mamounas E. Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg: Clin. N. Am. 83,931-942 (2003).
   Google Scholar
• ••Review of SLNB in the setting ofneoadjuvant chemotherapy. Reports false-negative rate of 7% in multi-institutional experience of patients participating in NSABP B-27 who underwent SLNB followed by axillary lymph node dissection after neoadjuvant chemotherapy.
   Google Scholar
• Sabel MS, Schott AF, Kleer CG et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. AM. I Surg: 186,102–105 (2003).
   PubMed Web of Science ®Google Scholar
• Cox CE, Nguyen K, Gray RJ et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg. 67,513–519 (2001).
   Google Scholar
• Kuehn T, Vogel FD, Helms G et al. Sentinel node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur j Surg. Oncol 30,252–259 (2004).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Engl j Merl 349, 546–533 (2003).
   PubMed Web of Science ®Google Scholar
• ••Randomized trial in patients with smalltumors comparing SLNB followed by routine axillary node dissection versus SLNB followed by axillary node dissection only in patients with a positive sentinel node.
   Google Scholar
• Martin RC, Derossis AM, Fey J et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgety130,432–438 (2001).
   PubMed Web of Science ®Google Scholar
• McMasters KM, Wong SL, Martin RC II et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study. Ann. Surg: 233,676-687 (2001).
   Google Scholar
• KLauber-DeMore N, Tan LK, Liberman L et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Ann. Surg. Oncol 7,636–642 (2000).
   Google Scholar
• Cox CE, Nguyen K, Gray RJ et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am. Surg. 67,513–521 (2001).
   Google Scholar
• Tamhane R, Dahlstrom JE, McCallum DD et al. The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma in situ. Ann. Surg: Oncol 9,999–1003 (2002).
   PubMed Web of Science ®Google Scholar
• McMasters KM, Chao C, Wong SL et al. Sentinel lymph node biopsy in ductal carcinoma in situ: a proposal. Cancer 95, 15–20 (2002).
   PubMed Web of Science ®Google Scholar
• •Algorithm of use of SLNB in ductal carcinoma in situ.
   Google Scholar
• McMasters KM. Current status of sentinel node biopsy for breast cancer. The Krag/Harlow article reviewed. Oncology 17(12), 1669–1675 (2003).
   Google Scholar
• Clarke D, Khonji NI, Mansel RE. Sentinel node biopsy in breast cancer: ALMANAC Trial. World J. Surg: 25,819-822 (2001).
   Google Scholar